The Draft Environmental Impact Statement for Post-2026 Operations of Lake Powell and Lake Mead The Colorado River Basin, a ...

ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Rajasthan Public Service Commission has declared the final results for the RAS 2025 examination, confirming 2,219 selections for administrative and subordinate posts. The competitive exam, comprising ...

RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

A meeting of the search committee regarding the appointment of a permanent Chairman of the Higher Education Commission (HEC) was held on Wednesday, while Education Secretary Nadeem Mahbub has assumed ...

The federal government has appointed Secretary Education Nadeem Mahbub as the acting chairman of Higher Education Commission since Dr Mukhtar Ahmed’s term has ended. The Ministry of Education has ...

ISLAMABAD – The court has reinstated Professor Dr. Zia-ul-Qayyum as the Executive Director of the Higher Education Commission (HEC) after suspending his termination orders issued earlier this year.

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.